Cite
HARVARD Citation
Moya, B. et al. (2022). First confirmed case of nonimmediate hypersensitivity to fremanezumab during chronic migraine treatment. Contact dermatitis. pp. 308-310. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moya, B. et al. (2022). First confirmed case of nonimmediate hypersensitivity to fremanezumab during chronic migraine treatment. Contact dermatitis. pp. 308-310. [Online].